PCN Live 2023 Programme

Time Information
8:00 AM - 9:00 AM
Registration & exhibition viewing

9:10 AM - 9:55 AM
Best Practice in delivery and management of immunisation services
Helen Donovan, Independent Nurse consultant immunisation specialist nurse,

This session will look at how best to ensure best practice in vaccine administration and delivery of immunisation services. Maintaining patient safety and public trust is fundamental to the delivery of vaccine programmes. Immunisers need to be appropriately trained and educated to work to best practice standards. They also need to make sure they keep up to date with changes to the national vaccine programme as it evolves to best serve and protect our population.

The session will consider why this is important and provide an overview for practitioners to help ensure they can keep delivering safe quality immunisation services
10:00 AM - 10:45 AM
Shingles: The time is now to help protect your patients
Dr Catherine Heffernan, Director of Health Improvement & SWL Public Health Consultant, SWL ICB & South London Partnership

This session will cover: 'The Burden of Shingles' and 'The Shingles National Immunisation Programme'

This session is kindly sponsored by GSK.
10:45 AM - 11:05 AM
Morning break & exhibition viewing

11:10 AM - 11:55 AM
When to suspect COPD: capturing the undiagnosed
Catherine Ren Lawlor, Advanced Nurse Practitioner, Academic Tutor, South East London Training Hub Director at The Good Practitioner - Education and Training

Will focus on the importance of early diagnosis of COPD. Where to find the undiagnosed and action to take in early disease to reduce impact and burden.
12:00 PM - 12:25 PM
Break & exhibition viewing

12:25 PM - 1:10 PM
Rescue to prevention - The growing need for earlier and proactive interventions in COPD
Jacqueline Brereton, Paediatric & Adult Respiratory Nurse Consultant, Healthier South Wirral PCN

This is a promotional symposium sponsored and organised by AstraZeneca.

1:10 PM - 2:00 PM
Lunch & exhibition viewing

2:00 PM - 2:45 PM
Let’s Tackle Diabetes Now : the iDEAL Way
Dr Anne Phillips, Professor in Advancing Diabetes Care, Birmingham City University

Diabetes is a global problem and health inequalities are becoming increasing prevalent especially post pandemic. Practitioners can identify health needs unique to their local populations and also identify gaps in local health needs and diabetes care requirements. Acting now to identify these gaps with easy to fill patient facing solutions can help the most vulnerable in our society to reach effective and efficient diabetes education and care approaches. This also assists busy practitioners with increasing complicated treatment options to share with their patients who can be vulnerable and in need. Let’s tackle diabetes now offers solutions for practice nurses and primary care practitioners to enable them to deliver holistic and person centred inclusive diabetes care approaches.
2:55 PM - 3:40 PM
Comprehensive Kidney Care: What does this mean for patients with T2D?
Mr Niraj Lakhani, Lead Clinical Pharmacist and Superintendent Pharmacist, Pharmacist Adviser to the Royal College of General Practitioners (RCGP) for Primary Care Development

This is a promotional symposium sponsored and organised by AstraZeneca.

3:40 PM - 3:55 PM
Afternoon break & exhibition viewing

3:55 PM - 4:40 PM
“But I don’t eat anything doctor”: NAFLD or MAFLD: should you care?
Dr Jude A Oben, Consultant Gastroenterologist-Hepatologist, Guy’s and St Thomas’ Hospital

25% of the global population have Non-Alcoholic-Fatty-Liver-Disease(NAFLD) with ~6% having non-alcoholic-steatohepatitis(NASH). Possible name, change from NAFLD to MAFLD(Metabolic associated fatty liver disease). Shift to reflect underlying pathogenesis, eliminate “negative” nomenclature, and allow for coexistence of other chronic liver diseases, including alcoholic liver disease.

What’s in a name? MAFLD, NAFLD, or Obesity-induced-liver-disease: should we care? NAFLD ranges from steatosis to NASH, cirrhosis and hepatocellular cancer. Since Steatosis can proceed directly to hepatocellular, we should not refer to it as simple steatosis!!

Mechanistically, maternal obesity programs development of offspring obesity and NAFLD. Maternal gut microbiota may be involved in programming... Many upcoming therapies……..